Day: August 1, 2024

Russia donates cholera commodities to Zim

Kuda Pembere

By Kudakwashe Pembere Insofar as Zimbabwe has declared itself cholera free after 30 days without recording a case, the Russian Federation handed over to the Health and Child Care Ministry cholera medication and equipment worth over US$43 000 to enhance the country’s preparedness should another cholera outbreak emerge. Speaking at a handover ceremony at the National Pharmaceutical Company warehouse in Harare on Thursday, the Health Minister Dr Douglas Mombeshora said the commodities to fight cholera remain critical. “The donation with a value of $43 853,40 consisting of consisting of intravenous…

Read More

Care groups as a vehicle for Supporting breastfeeding mothers

Caroline Chiimba

By Caroline Chiimba Breastfeeding gives children the healthiest start in life, as breast-milk promotes cognitive child development and acts as a baby’s first vaccine, giving babies a critical boost. Nutrition Action Zimbabwe (NAZ) joins the world in commemorating World Breastfeeding Week celebrated from 1-7 August under the theme, ‘Closing the gap: Breastfeeding support for all.’ In its programming, NAZ has always placed emphasis on exclusive breastfeeding for the first 6 months and continued breastfeeding with appropriate complimentary feeds up to two years and beyond. Breastfeeding proffers lifesaving benefits and is…

Read More

Viagra drug improves brain blood flow and could help to prevent dementia

Healthtimes

A University of Oxford trial has shown that sildenafil, commonly known as Viagra, enhances blood flow to the brain and improves the function of brain blood vessels in patients at a heightened risk of vascular dementia.   This new study, published in Circulation Research and supported by the NIHR Oxford   Biomedical Research Centre (BRC), marks a potentially pivotal step in the fight against this debilitating condition. Dr Alastair Webb, Associate Professor at the Wolfson Centre for Prevention of Stroke and Dementia at Oxford University, said: “This is the first trial to…

Read More